Brief Communication on Pathologic Assessment of Persistent Stable Metastatic Lesions in Patients Treated With Anti-CTLA-4 or Anti-CTLA-4 + Anti-PD-1 Therapy

Despite the wide use of immune checkpoint inhibition for the treatment of melanoma, the mechanisms leading to long-term stable disease are incompletely understood. Patients with metastatic melanoma who had received ipilimumab alone or ipilimumab plus nivolumab 2+years prior and attained at least 6 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchbinder, Elizabeth I., Pfaff, Kathleen L., Turner, Madison M., Manos, Michael, Ouyang, Olivia, Ott, Patrick A., Giobbie-Hurder, Anita, Rodig, Scott J., Hodi, F. Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168111/
https://www.ncbi.nlm.nih.gov/pubmed/37115942
http://dx.doi.org/10.1097/CJI.0000000000000470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168111/
https://www.ncbi.nlm.nih.gov/pubmed/37115942
http://dx.doi.org/10.1097/CJI.0000000000000470

Ejemplares similares